IRIDEX Corporation

IRIDEX Corporation provides laser systems and instrumentation for treating sight-threatening eye diseases. Products include Cyclo G6, IQ 532, IQ 577, OcuLight, and MicroPulse laser consoles. The company also offers delivery devices such as TxCell, slit lamp adapter, and laser indirect ophthalmoscope. These products are used to treat glaucoma, retinal disorders, proliferative diabetic retinopathy, macular holes, and detachments. IRIDEX serves ophthalmologists, hospitals, surgical centers, veterinary practices, and office clinics in the US and internationally. The company was incorporated in 1989 and is headquartered in Mountain View, California.

Overview

Sector

Medical Devices

Target Price

0.0 USD

Current Price

1.2 USD

Potential

-100%

Strengths

No significant strengths identified based on the analyzed metrics.

Weaknesses

With a depreciation Potential of -100.00%, based on our fundamental analysis, it suggests the stock may be overvalued.
Analysts expect revenues to decline in the coming year.
The company has high debt. Net Debt to EBITDA Ratio (100.00) is higher than the sector mean.
The company have lower returns than the sector in which it operates. ROIC (0.00%) is significantly lower than the sector mean (2.97%).
EV/EBIT (100.00) is significantly higher than the sector mean.
EBITDA Margin (0.00%) appears relatively low.

Key Financial Data

Indicator	Value
PER	100.0
EV/EBITDA	100.0
Price/Free Cash Flow'	100.0
ROIC	-%
Net Debt/EBITDA	100.0